Device Trial Radar · NCT03940573
Pursuit: Real World Use of the Eclipse System
Last checked: Nov 20, 2026Latest source record: Mar 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Planned (sponsor's estimate)
Start
Apr 19, 2019
Primary completion
Dec 31, 2021
Study completion Dec 31, 2021
Sponsor
- Lead sponsor
- Pelvalon, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 7, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, open label post-market registry to collect Patient Reported Outcomes and Fitting metrics (e.g. sizes used) in subjects using the Eclipse System in a commercial setting.
Conditions
- Fecal Incontinence
Interventions
Eclipse InsertDevice
Rectal Control System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Fit RateTime frame: Data collected at fitting visits (max 3 attempts), 5-7 weeks from initial screening
3 more outcomes with a free account
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
The American Association of Female Pelvic Medicine
Agoura Hills, California · Recruiting
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.